Changing prevalence and treatment of depression among older people over two decades.
Changing prevalence and treatment of depression among older people over two decades.
复制标题
DOI:
10.1192/bjp.2019.193
复制
发表时间:
2020-01
期刊:
影响因子:
--
通讯作者:
Cognitive Function and Ageing Studies Collaboration
中科院分区:
文献类型:
--
作者:
Arthur A;Savva GM;Barnes LE;Borjian-Boroojeny A;Dening T;Jagger C;Matthews FE;Robinson L;Brayne C;Cognitive Function and Ageing Studies Collaboration
Depression is a leading cause of disability, with older people particularly susceptible to poor outcomes. To investigate whether the prevalence of depression and antidepressant use have changed across two decades in older people. The Cognitive Function and Ageing Studies (CFAS I and CFAS II) are two English population-based cohort studies of older people aged ≥65 years, with baseline measurements for each cohort conducted two decades apart (between 1990 and 1993 and between 2008 and 2011). Depression was assessed by the Geriatric Mental State examination and diagnosed with the Automated Geriatric Examination for Computer-Assisted Taxonomy algorithm. In CFAS I, 7635 people aged ≥65 years were interviewed, of whom 1457 were diagnostically assessed. In CFAS II, 7762 people were interviewed and diagnostically assessed. Age-standardised depression prevalence in CFAS II was 6.8% (95% CI 6.3–7.5%), representing a non-significant decline from CFAS I (risk ratio 0.82, 95% CI 0.64–1.07, P = 0.14). At the time of CFAS II, 10.7% of the population (95% CI 10.0–11.5%) were taking antidepressant medication, more than twice that of CFAS I (risk ratio 2.79, 95% CI 1.96–3.97, P < 0.0001). Among care home residents, depression prevalence was unchanged, but the use of antidepressants increased from 7.4% (95% CI 3.8–13.8%) to 29.2% (95% CI 22.6–36.7%). A substantial increase in the proportion of the population reporting taking antidepressant medication is seen across two decades for people aged ≥65 years. However there was no evidence for a change in age-specific prevalence of depression.
登录
查看更多内容
影响因子:
168.9
作者:
Matthews, Fiona E.;Arthur, Antony;Barnes, Linda E.;Bond, John;Jagger, Carol;Robinson, Louise;Brayne, Carol
通讯作者:
Brayne, Carol
DOI:
10.1097/nmd.0b013e3181b0c081
发表时间:
2009-08
期刊:
The Journal of nervous and mental disease
影响因子:
--
作者:
Wetherell JL;Petkus AJ;McChesney K;Stein MB;Judd PH;Rockwell E;Sewell DD;Patterson TL
通讯作者:
Patterson TL
DOI:
10.1080/00048670601050465
发表时间:
2007-01-01
影响因子:
4.6
作者:
Goldney, Robert D.;Fisher, Laura J.;Hawthorne, Graerne
通讯作者:
Hawthorne, Graerne
DOI:
10.5455/msm.2016.28.129-132
发表时间:
2016-04-01
期刊:
Materia socio-medica
影响因子:
--
作者:
Zelko, Erika;Klemenc-Ketis, Zalika;Tusek-Bunc, Ksenija
通讯作者:
Tusek-Bunc, Ksenija
影响因子:
7.8
作者:
Aarts, N.;Noordam, R.;Visser, L. E.
通讯作者:
Visser, L. E.